Skip to main content
Erschienen in: Heart and Vessels 11/2019

26.04.2019 | Original Article

Clinical impact of the gap-angle ratio in patients with ostial lesions of the right coronary artery undergoing percutaneous coronary intervention

verfasst von: Koichi Ohashi, Daisuke Abe, Norihiro Kuroki, Takao Yuba, Kou Suzuki

Erschienen in: Heart and Vessels | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to investigate the incidence of binary restenosis and its predictors in patients with ostial lesions of the right coronary artery (RCAos) who underwent percutaneous coronary intervention (PCI). RCAos are associated with a high incidence of restenosis, and the implantations of drug-eluting stents for RCAos have not been fully elucidated. The study participants included 75 patients (72.3 ± 9.5 years, 72% men) who underwent PCI for RCAos at our institution between November 2001 and May 2017. The angle between the greater curvature of the aortic wall and the right coronary artery take-off in the diastolic and systolic phases in the left anterior oblique position view was investigated. Clinical outcome was defined as binary restenosis at follow-up coronary angiography. We also evaluated target lesion failure (TLF) defined as a composite of cardiac mortality, target vessel myocardial infarction, and target lesion revascularization (TLR). The incidence of binary restenosis was 48.0% (n = 36) of the entire cohort. The incidence of TLF was 49.3% (n = 37) of the entire cohort, which was mainly driven by TLR (36.0%, n = 27). The area under the curve of the gap-angle ratio [(difference between the maximum and minimum angles)/(minimum angle); GAR] for binary restenosis was 0.73, and the cutoff value was 0.306 (sensitivity 67%, specificity 82%). The patients were divided into two groups: a low-GAR (< 0.306; n = 30) and high-GAR group (> 0.306; n = 45). Binary restenosis was more frequent in the high-GAR group than in the low-GAR group (76.7% vs. 28.9%, p = 0.007). The cumulative rate of TLF was significantly higher in the high-GAR group when compared with the low-GAR group (53.3% vs. 40.0%, p = 0.01), which was mainly driven by TLR (56.7% vs. 22.2%, p = 0.01). High-GAR (> 0.306) [OR 2.66 (1.34–5.31), p = 0.005] and stent under expansion [OR 2.37 (1.10–5.11), p = 0.03] were found to be independent predictors of binary restenosis after adjustment for multiple confounders. Multivariable analysis also revealed that high-GAR (> 0.306) [OR 2.06 (1.02–4.14), p = 0.03] and stent under expansion [OR 2.82 (1.28–6.19), p = 0.01] were independent predictors of TLF. We suggest that GAR (> 0.306) predicts binary restenosis and TLF in patients undergoing PCI for RCAos.
Literatur
1.
Zurück zum Zitat Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, McFadden E, Sianos G, Smits PC, Hofma SH, de Feyter PJ, van Domburg RT, Serruys PW (2004) Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 109:1366–1370CrossRef Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, McFadden E, Sianos G, Smits PC, Hofma SH, de Feyter PJ, van Domburg RT, Serruys PW (2004) Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 109:1366–1370CrossRef
2.
Zurück zum Zitat Mavromatis K, Ghazzal Z, Veledar E, Diamandopoulos L, Weintraub WS, Douglas JS, Kalynych AM (2004) Comparison of outcomes of percutaneous coronary intervention of ostial versus nonostial narrowing of the major epicardial coronary arteries. Am J Cardiol 94:583–587CrossRef Mavromatis K, Ghazzal Z, Veledar E, Diamandopoulos L, Weintraub WS, Douglas JS, Kalynych AM (2004) Comparison of outcomes of percutaneous coronary intervention of ostial versus nonostial narrowing of the major epicardial coronary arteries. Am J Cardiol 94:583–587CrossRef
3.
Zurück zum Zitat Freeman M, Clark DJ, Andrianopoulos N, Duffy SJ, Lim HS, Brennan A, Charter K, Shaw J, Horrigan M, Ajani AE, Sebastian M, Reid CM, Farouque HM, Melbourne Interventional Group (2009) Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents. Catheter Cardiovasc Interv 73:763–768CrossRef Freeman M, Clark DJ, Andrianopoulos N, Duffy SJ, Lim HS, Brennan A, Charter K, Shaw J, Horrigan M, Ajani AE, Sebastian M, Reid CM, Farouque HM, Melbourne Interventional Group (2009) Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents. Catheter Cardiovasc Interv 73:763–768CrossRef
4.
Zurück zum Zitat Hur SH, Kang SJ, Kim YH, Ahn JM, Park DW, Lee SW, Yun SC, Lee CW, Park SW, Park SJ (2013) Impact of intravascular ultrasound-guided percutaneous coronary intervention on long-term clinical outcomes in a real world population. Catheter Cardiovasc Interv 81:407–416CrossRef Hur SH, Kang SJ, Kim YH, Ahn JM, Park DW, Lee SW, Yun SC, Lee CW, Park SW, Park SJ (2013) Impact of intravascular ultrasound-guided percutaneous coronary intervention on long-term clinical outcomes in a real world population. Catheter Cardiovasc Interv 81:407–416CrossRef
5.
Zurück zum Zitat Chin K (2001) An approach to ostial lesion management. Curr Interv Cardiol Rep 3:87–89PubMed Chin K (2001) An approach to ostial lesion management. Curr Interv Cardiol Rep 3:87–89PubMed
6.
Zurück zum Zitat Toutouzas K, Stankovic G, Takagi T, Spanos V, DiMario C, Albiero R, Corvaja N, Gaglione A, Colombo A (2002) Outcome of treatment of aorto-ostial lesions involving the right coronary artery or a saphenous vein graft with a polytetrafluoroethylene-covered stent. Am J Cardiol 90:63–66CrossRef Toutouzas K, Stankovic G, Takagi T, Spanos V, DiMario C, Albiero R, Corvaja N, Gaglione A, Colombo A (2002) Outcome of treatment of aorto-ostial lesions involving the right coronary artery or a saphenous vein graft with a polytetrafluoroethylene-covered stent. Am J Cardiol 90:63–66CrossRef
7.
Zurück zum Zitat Moussa I, Moses J, Di Mario C, Busi G, Reimers B, Kobayashi Y, Albiero R, Ferraro M, Colombo A (1998) Stenting after optimal lesion debulking (sold) registry. Angiographic and clinical outcome. Circulation 98:1604–1609CrossRef Moussa I, Moses J, Di Mario C, Busi G, Reimers B, Kobayashi Y, Albiero R, Ferraro M, Colombo A (1998) Stenting after optimal lesion debulking (sold) registry. Angiographic and clinical outcome. Circulation 98:1604–1609CrossRef
8.
Zurück zum Zitat Zampieri P, Colombo A, Almagor Y, Maiello L, Finci L (1994) Results of coronary stenting of ostial lesions. Am J Cardiol 73:901–903CrossRef Zampieri P, Colombo A, Almagor Y, Maiello L, Finci L (1994) Results of coronary stenting of ostial lesions. Am J Cardiol 73:901–903CrossRef
9.
Zurück zum Zitat Iakovou I, Ge L, Michev I, Sangiorgi GM, Montorfano M, Airolde F, Chieffo A, Stankovic G, Vitrella G, Carlino M, Corvaja N, Briguori C, Colombo A (2004) Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions. J Am Coll Cardiol 44:967–971CrossRef Iakovou I, Ge L, Michev I, Sangiorgi GM, Montorfano M, Airolde F, Chieffo A, Stankovic G, Vitrella G, Carlino M, Corvaja N, Briguori C, Colombo A (2004) Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions. J Am Coll Cardiol 44:967–971CrossRef
10.
Zurück zum Zitat Jain SP, Liu MW, Dean LS, Babu R, Goods CM, Yadav JS, Al-Shaibi KF, Mathur A, Iyer SS, Parks JM, Baxley WA, Roubin GS (1997) Comparison of balloon angioplasty versus debulking devices versus stenting in right coronary ostial lesions. Am J Cardiol 79:1334–1338CrossRef Jain SP, Liu MW, Dean LS, Babu R, Goods CM, Yadav JS, Al-Shaibi KF, Mathur A, Iyer SS, Parks JM, Baxley WA, Roubin GS (1997) Comparison of balloon angioplasty versus debulking devices versus stenting in right coronary ostial lesions. Am J Cardiol 79:1334–1338CrossRef
11.
Zurück zum Zitat Luz A, Hughes C, Magalhães R, Bisceglia T, Descoutures F, Tamamm K, Tchetche D, Sauguet A, Farah B, Fajadet J (2012) Stent implantation in aorto-ostial lesions: long-term follow-up and predictors of outcome. EuroIntervention 7:1069–1076CrossRef Luz A, Hughes C, Magalhães R, Bisceglia T, Descoutures F, Tamamm K, Tchetche D, Sauguet A, Farah B, Fajadet J (2012) Stent implantation in aorto-ostial lesions: long-term follow-up and predictors of outcome. EuroIntervention 7:1069–1076CrossRef
12.
Zurück zum Zitat von Birgelen C, Basalus MW, Tandjung K, van Houwelingen KG, Stoel MG, Louwerenburg JH, Linssen GC, Saïd SA, Kleijne MA, Sen H, Löwik MM, van der Palen J, Verhorst PM, de Man FH (2012) A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial. J Am Coll Cardiol 59:1350–1361CrossRef von Birgelen C, Basalus MW, Tandjung K, van Houwelingen KG, Stoel MG, Louwerenburg JH, Linssen GC, Saïd SA, Kleijne MA, Sen H, Löwik MM, van der Palen J, Verhorst PM, de Man FH (2012) A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial. J Am Coll Cardiol 59:1350–1361CrossRef
13.
Zurück zum Zitat Tandjung K, Sen H, Lam MK, Basalus MWZ, Louwerenburg JHW, Stoel MG, van Houwelingen KG, de Man FHAF, Linssen GCM, Saïd SAM, Nienhuis MB, Löwik MM, Verhorst PM, van der Palen J, von Birgelen C (2013) Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trial. J Am Coll Cardiol 61:2406–2416CrossRef Tandjung K, Sen H, Lam MK, Basalus MWZ, Louwerenburg JHW, Stoel MG, van Houwelingen KG, de Man FHAF, Linssen GCM, Saïd SAM, Nienhuis MB, Löwik MM, Verhorst PM, van der Palen J, von Birgelen C (2013) Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trial. J Am Coll Cardiol 61:2406–2416CrossRef
14.
Zurück zum Zitat Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Ronden J, Bressers M, Gobbens P, Negoita M, van Leeuwen F, Windecker S (2010) Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med 363(2):136–146CrossRef Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Ronden J, Bressers M, Gobbens P, Negoita M, van Leeuwen F, Windecker S (2010) Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med 363(2):136–146CrossRef
15.
Zurück zum Zitat Muni NI, Gross TP (2004) Problems with drug-eluting coronary stents–the FDA perspective. N Engl J Med 351:1593–1594CrossRef Muni NI, Gross TP (2004) Problems with drug-eluting coronary stents–the FDA perspective. N Engl J Med 351:1593–1594CrossRef
16.
Zurück zum Zitat Kanda Y (2012) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl 48:452–458CrossRef Kanda Y (2012) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl 48:452–458CrossRef
17.
Zurück zum Zitat Topol EJ, Ellis SG, Fishman J, Leimgruber P, Myler RK, Stertzer SH, O’Neill WW, Douglas JS, Roubin GS, King SB 3rd (1987) Multicenter study of percutaneous transluminal angioplasty for right coronary artery ostial stenosis. J Am Coll Cardiol 9:1214–1218CrossRef Topol EJ, Ellis SG, Fishman J, Leimgruber P, Myler RK, Stertzer SH, O’Neill WW, Douglas JS, Roubin GS, King SB 3rd (1987) Multicenter study of percutaneous transluminal angioplasty for right coronary artery ostial stenosis. J Am Coll Cardiol 9:1214–1218CrossRef
18.
Zurück zum Zitat Leimgruber PP, Roubin GW, Hollman J, Cotsonis GA, Meier B, Douglas JS, King SB Jr, Gruentzig AR (1986) Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 73:710–717CrossRef Leimgruber PP, Roubin GW, Hollman J, Cotsonis GA, Meier B, Douglas JS, King SB Jr, Gruentzig AR (1986) Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 73:710–717CrossRef
19.
Zurück zum Zitat Holmes DR Jr, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, Faxon DP, Gruentzig AR, Kelsey SF, Detre KM, Van Raden MJ, Mock MB (1984) Restenosis after percutaneous transluminal coronary angiography (PTCA): a report from the PTCA registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 53:77C–81CCrossRef Holmes DR Jr, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, Faxon DP, Gruentzig AR, Kelsey SF, Detre KM, Van Raden MJ, Mock MB (1984) Restenosis after percutaneous transluminal coronary angiography (PTCA): a report from the PTCA registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 53:77C–81CCrossRef
20.
Zurück zum Zitat Tsunoda T, Nakamura M, Wada M, Ito N, Kitagawa Y, Shiba M, Yajima S, Iijima R, Nakajima R, Yamamoto M, Takagi T, Yoshitama T, Anzai H, Nishida T, Yamaguchi T (2004) Chronic stent recoil plays an important role in restenosis of the right coronary ostium. Coron Artery Dis 15:39–44CrossRef Tsunoda T, Nakamura M, Wada M, Ito N, Kitagawa Y, Shiba M, Yajima S, Iijima R, Nakajima R, Yamamoto M, Takagi T, Yoshitama T, Anzai H, Nishida T, Yamaguchi T (2004) Chronic stent recoil plays an important role in restenosis of the right coronary ostium. Coron Artery Dis 15:39–44CrossRef
21.
Zurück zum Zitat Popma JJ, Brogan WC 3rd, Pichard AD, Satler LF, Kent KM, Mintz GS, Leon MB (1993) Rotational coronary atherectomy of ostial stenosis. Am J Cardiol 71:436–438CrossRef Popma JJ, Brogan WC 3rd, Pichard AD, Satler LF, Kent KM, Mintz GS, Leon MB (1993) Rotational coronary atherectomy of ostial stenosis. Am J Cardiol 71:436–438CrossRef
22.
Zurück zum Zitat Eigler NL, Weinstock B, Douglas JS Jr, Goldenberg T, Hartzler G, Holmes D, Leon M, Margolis J, Nobuyoshi M, O’Neill W, Rothbaum D, Roubin G, Untereker W, Cowley M, Forrester J, Litvack F (1993) Excimer laser coronary angioplasty of aorto-ostial stenosis. Results of the excimer laser coronary angioplasty (ELCA) registry in the first 200 patients. Circulation 88:2049–2057CrossRef Eigler NL, Weinstock B, Douglas JS Jr, Goldenberg T, Hartzler G, Holmes D, Leon M, Margolis J, Nobuyoshi M, O’Neill W, Rothbaum D, Roubin G, Untereker W, Cowley M, Forrester J, Litvack F (1993) Excimer laser coronary angioplasty of aorto-ostial stenosis. Results of the excimer laser coronary angioplasty (ELCA) registry in the first 200 patients. Circulation 88:2049–2057CrossRef
23.
Zurück zum Zitat Mitomo S, Jabbour RJ, Watanabe Y, Mangieri A, Ancona M, Regazzoli D, Tanaka A, Nakajima A, Naganuma T, Giannini F, Latib A, Nakamura S, Colombo A (2018) Comparison of mid-term clinical outcomes after treatment of ostial right coronary artery lesions with early and new generation drug-eluting stents: insights from an international multicenter registry. Int J Cardiol 254:53–58CrossRef Mitomo S, Jabbour RJ, Watanabe Y, Mangieri A, Ancona M, Regazzoli D, Tanaka A, Nakajima A, Naganuma T, Giannini F, Latib A, Nakamura S, Colombo A (2018) Comparison of mid-term clinical outcomes after treatment of ostial right coronary artery lesions with early and new generation drug-eluting stents: insights from an international multicenter registry. Int J Cardiol 254:53–58CrossRef
24.
Zurück zum Zitat Song HG, Kang SJ, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Park SW (2014) Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation. Catheter Cardiovasc Interv 83:873–878CrossRef Song HG, Kang SJ, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Park SW (2014) Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation. Catheter Cardiovasc Interv 83:873–878CrossRef
25.
Zurück zum Zitat Aviram G, Shmilovich H, Finkelstein A, Rosen G, Banai S, Graif M, Keren GB (2006) Coronary ostium-straight tube or funnel-shaped? A computerized tomographic coronary angiography study. Acute Card Care 8:224–228CrossRef Aviram G, Shmilovich H, Finkelstein A, Rosen G, Banai S, Graif M, Keren GB (2006) Coronary ostium-straight tube or funnel-shaped? A computerized tomographic coronary angiography study. Acute Card Care 8:224–228CrossRef
26.
Zurück zum Zitat Rubinshtein R, Ben-Dov N, Halon DA, Lavi I, Finkelstein A, Lewis BS, Jaffe R, Davis L (2015) Geographic miss with aorto-ostial coronary stent implantation: insights from high-resolution coronary computed tomography angiography. EuroIntervention 11:301–307CrossRef Rubinshtein R, Ben-Dov N, Halon DA, Lavi I, Finkelstein A, Lewis BS, Jaffe R, Davis L (2015) Geographic miss with aorto-ostial coronary stent implantation: insights from high-resolution coronary computed tomography angiography. EuroIntervention 11:301–307CrossRef
Metadaten
Titel
Clinical impact of the gap-angle ratio in patients with ostial lesions of the right coronary artery undergoing percutaneous coronary intervention
verfasst von
Koichi Ohashi
Daisuke Abe
Norihiro Kuroki
Takao Yuba
Kou Suzuki
Publikationsdatum
26.04.2019
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 11/2019
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-019-01417-x

Weitere Artikel der Ausgabe 11/2019

Heart and Vessels 11/2019 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.